The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.

The Warburg effect is a tumorigenic metabolic adaptation process characterized by augmented aerobic glycolysis, which enhances cellular bioenergetics. In normal cells, energy homeostasis is controlled by AMPK; however, its role in cancer is not understood, as both AMPK-dependent tumor-promoting and -inhibiting functions were reported. Upon stress, energy levels are maintained by increased mitochondrial biogenesis and glycolysis, controlled by transcriptional coactivator PGC-1α and HIF, respectively. In normoxia, AMPK induces PGC-1α, but how HIF is activated is unclear. Germline mutations in the gene encoding the tumor suppressor folliculin (FLCN) lead to Birt-Hogg-Dubé (BHD) syndrome, which is associated with an increased cancer risk. FLCN was identified as an AMPK binding partner, and we evaluated its role with respect to AMPK-dependent energy functions. We revealed that loss of FLCN constitutively activates AMPK, resulting in PGC-1α-mediated mitochondrial biogenesis and increased ROS production. ROS induced HIF transcriptional activity and drove Warburg metabolic reprogramming, coupling AMPK-dependent mitochondrial biogenesis to HIF-dependent metabolic changes. This reprogramming stimulated cellular bioenergetics and conferred a HIF-dependent tumorigenic advantage in FLCN-negative cancer cells. Moreover, this pathway is conserved in a BHD-derived tumor. These results indicate that FLCN inhibits tumorigenesis by preventing AMPK-dependent HIF activation and the subsequent Warburg metabolic transformation.

[1]  Jayantha B. Tennakoon,et al.  Androgens Regulate Prostate Cancer Cell Growth via an AMPK-PGC-1α-Mediated Metabolic Switch , 2013, Oncogene.

[2]  G. Mills,et al.  LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer , 2013, Cancer & metabolism.

[3]  V. Giguère,et al.  The PGC-1/ERR signaling axis in cancer , 2013, Oncogene.

[4]  I. Mylonis,et al.  MgcRacGAP, a cytoskeleton regulator, inhibits HIF-1 transcriptional activity by blocking its dimerization. , 2013, Biochimica et biophysica acta.

[5]  V. P. Collins,et al.  The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation , 2013, Cell.

[6]  G. Mills,et al.  AMPK: a contextual oncogene or tumor suppressor? , 2013, Cancer research.

[7]  M. Pollak.  Targeting oxidative phosphorylation: why, when, and how. , 2013, Cancer cell.

[8]  G. Stephanopoulos,et al.  In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. , 2013, Cell metabolism.

[9]  Takla Griss,et al.  AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. , 2013, Cell metabolism.

[10]  K. Nagashima,et al.  Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. , 2012, Journal of the National Cancer Institute.

[11]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[12]  L. Seabra,et al.  Gene expression and protein array studies of folliculin-regulated pathways. , 2012, Anticancer research.

[13]  N. Bardeesy,et al.  LKB1-AMPK axis revisited , 2012, Cell Research.

[14]  G. Girnun.  The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer. , 2012, Seminars in cell & developmental biology.

[15]  M. Ohh,et al.  The updated biology of hypoxia‐inducible factor , 2012, The EMBO journal.

[16]  C. Deng,et al.  SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. , 2012, Cancer research.

[17]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[18]  Reinhard Guthke,et al.  Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. , 2012, Cell metabolism.

[19]  L. Zender,et al.  Deregulated MYC expression induces dependence upon AMPK-related kinase 5 , 2012, Nature.

[20]  W. Muller,et al.  PGC-1α promotes the growth of ErbB2/Neu-induced mammary tumors by regulating nutrient supply. , 2012, Cancer research.

[21]  B. Kemp,et al.  AMPK functions as an adenylate charge-regulated protein kinase , 2012, Trends in Endocrinology & Metabolism.

[22]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[23]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[24]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[25]  P. Puigserver,et al.  PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. , 2011, Cancer research.

[26]  E. Giannoni,et al.  HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. , 2011, Free radical biology & medicine.

[27]  C. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[28]  T. Finkel,et al.  Signal transduction by reactive oxygen species , 2011, The Journal of cell biology.

[29]  A. Pause,et al.  Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility , 2011, Oncogene.

[30]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[31]  Z. Nagy,et al.  Therapeutic Targeting the Loss of the Birt-Hogg-Dubé Suppressor Gene , 2011, Molecular Cancer Therapeutics.

[32]  Ximing J. Yang,et al.  Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression , 2010, BMC Medical Genomics.

[33]  Seung-Jae V. Lee,et al.  Inhibition of Respiration Extends C. elegans Life Span via Reactive Oxygen Species that Increase HIF-1 Activity , 2010, Current Biology.

[34]  W. Wong,et al.  Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.

[35]  W. Linehan,et al.  Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling , 2010, Molecular Cancer.

[36]  S. Gygi,et al.  Network organization of the human autophagy system , 2010, Nature.

[37]  W. Linehan,et al.  The genetic basis of kidney cancer: a metabolic disease , 2010, Nature Reviews Urology.

[38]  Mengwei Zang,et al.  AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. , 2010, Future oncology.

[39]  G. Semenza.  HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.

[40]  O. Hino,et al.  Serine 62 is a phosphorylation site in folliculin, the Birt–Hogg–Dubé gene product , 2010, FEBS letters.

[41]  D. Malo,et al.  Elevated Mitochondrial Reactive Oxygen Species Generation Affects the Immune Response via Hypoxia-Inducible Factor-1α in Long-Lived Mclk1+/− Mouse Mutants , 2009, The Journal of Immunology.

[42]  O. Hino,et al.  Regulation of folliculin (the BHD gene product) phosphorylation by Tsc2-mTOR pathway. , 2009, Biochemical and biophysical research communications.

[43]  Z. Zhai,et al.  The HIF-1 Hypoxia-Inducible Factor Modulates Lifespan in C. elegans , 2009, PloS one.

[44]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[45]  Alexander V. Zhdanov,et al.  PGC-1α is coupled to HIF-1α-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells , 2009, Proceedings of the National Academy of Sciences.

[46]  I. Kang,et al.  Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. , 2008, Carcinogenesis.

[47]  D. Peet,et al.  Turn me on: regulating HIF transcriptional activity , 2008, Cell Death and Differentiation.

[48]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[49]  Anja Voigt,et al.  Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. , 2007, Cell metabolism.

[50]  B. Spiegelman,et al.  AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α , 2007, Proceedings of the National Academy of Sciences.

[51]  T. Finkel.  Cell biology: A clean energy programme , 2006, Nature.

[52]  Jiandie D. Lin,et al.  Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators , 2006, Cell.

[53]  J. Hartley,et al.  Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling , 2006, Proceedings of the National Academy of Sciences.

[54]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[55]  P. Schumacker,et al.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. , 2005, Cell metabolism.

[56]  Peter L Choyke,et al.  Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. , 2005, American journal of human genetics.

[57]  Massimo Zeviani,et al.  Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. , 2005, Cell metabolism.

[58]  R. Scarpulla,et al.  Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. , 2004, Genes & development.

[59]  P. Reynier,et al.  PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. , 2003, Biochemical and biophysical research communications.

[60]  W. Linehan,et al.  Renal Tumors in the Birt-Hogg-Dubé Syndrome , 2002, The American journal of surgical pathology.

[61]  D. Scudiero,et al.  Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. , 2002, Cancer research.